European Respiratory Review

The European Respiratory Review (ERR) is an open access journal published by the European Respiratory Society (ERS), providing an update on medicine, science and surgery for respiratory professionals. The ERR contains state-of-the-art review articles, editorials and correspondence, in addition to summaries of the most important recent research findings and published studies in topics such as COPD, asthma, pulmonary hypertension, interstitial lung disease, lung cancer, tuberculosis and pulmonary infections. Articles are published continuously and collected into quarterly issues in one volume per year.

June

Editorials

Interstitial pneumonia with autoimmune features: a new classification still on the move Lorenzo Cavagna, Miguel A. Gonzalez Gay, Yannick Allanore, Marco Matucci-Cerinic Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018
Cell–matrix interactions in lung disease and regeneration: ERS Lung Science Conference 2018 report Silke Meiners, Clare Lloyd, Rachel C. Chambers Eur Respir Rev, 27 (148) 180040; 10.1183/16000617.0040-2018

Lung Science Conference

Matrix abnormalities in pulmonary fibrosis Chandak Upagupta, Chiko Shimbori, Rahmah Alsilmi, Martin Kolb Eur Respir Rev, 27 (148) 180033; 10.1183/16000617.0033-2018
The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease Dhiren F. Patel, Robert J. Snelgrove Eur Respir Rev, 27 (148) 180017; 10.1183/16000617.0017-2018
Acellular human lung scaffolds to model lung disease and tissue regeneration Sarah E. Gilpin, Darcy E. Wagner Eur Respir Rev, 27 (148) 180021; 10.1183/16000617.0021-2018
How bacteria hack the matrix and dodge the bullets of immunity Magnus Paulsson, Kristian Riesbeck Eur Respir Rev, 27 (148) 180018; 10.1183/16000617.0018-2018
The consequence of matrix dysfunction on lung immunity and the microbiome in COPD Tracy Hussell, Sylvia Lui, Christopher Jagger, David Morgan, Oliver Brand Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018

Health and Politics

Tuberculosis elimination: where are we now? Alberto Matteelli, Adrian Rendon, Simon Tiberi, Seif Al-Abri, Constantia Voniatis, Anna Cristina C. Carvalho, Rosella Centis, Lia D'Ambrosio, Dina Visca, Antonio Spanevello, Giovanni Battista Migliori Eur Respir Rev, 27 (148) 180035; 10.1183/16000617.0035-2018

Frontiers in Clincal Practice

A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators Stefano Ponzano, Giulia Nigrelli, Laura Fregonese, Irmgard Eichler, Fabio Bertozzi, Tiziano Bandiera, Luis J.V. Galietta, Marisa Papaluca Eur Respir Rev, 27 (148) 170124; 10.1183/16000617.0124-2017

Reviews

The role of cardiopulmonary exercise tests in pulmonary arterial hypertension Stefania Farina, Michele Correale, Noemi Bruno, Stefania Paolillo, Elisabetta Salvioni, Roberto Badagliacca, Piergiuseppe Agostoni Eur Respir Rev, 27 (148) 170134; 10.1183/16000617.0134-2017
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease Melissa Caron, Sabrina Hoa, Marie Hudson, Kevin Schwartzman, Russell Steele Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017
Interpreting risk reduction in clinical trials for pulmonary arterial hypertension Annie C. Lajoie, Sébastien Bonnet, Yves Lacasse, Jean-Christophe Lega, Steeve Provencher Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysis Mario Cazzola, Luigino Calzetta, Peter J. Barnes, Gerard J. Criner, Fernando J. Martinez, Alberto Papi, Maria Gabriella Matera Eur Respir Rev, 27 (148) 180010; 10.1183/16000617.0010-2018
Indoor mould exposure, asthma and rhinitis: findings from systematic reviews and recent longitudinal studies Denis Caillaud, Benedicte Leynaert, Marion Keirsbulck, Rachel Nadif Eur Respir Rev, 27 (148) 170137; 10.1183/16000617.0137-2017
State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advances Gianluca Sambataro, Domenico Sambataro, Sebastiano Emanuele Torrisi, Ada Vancheri, Mauro Pavone, Roberta Rosso, Matteo Schisano, Claudia Crimi, Francesca Pignataro, Aryeh Fischer, Nicoletta Del Papa, Carlo Vancheri Eur Respir Rev, 27 (148) 170139; 10.1183/16000617.0139-2017
COPD stands for complex obstructive pulmonary disease Sarah Houben-Wilke, Ingrid M. Augustin, Jan H. Vercoulen, Dirk van Ranst, Eline bij de Vaate, Johan B. Wempe, Martijn A. Spruit, Emiel F.M. Wouters, Frits M.E. Franssen Eur Respir Rev, 27 (148) 180027; 10.1183/16000617.0027-2018
Should I stay or should I go? COPD and air travel Begum Ergan, Metin Akgun, Angela Maria Grazia Pacilli, Stefano Nava Eur Respir Rev, 27 (148) 180030; 10.1183/16000617.0030-2018

Personalised Medicine in Respiratory Diseases

Personalised medicine in interstitial lung diseases Maria A. Kokosi, George A. Margaritopoulos, Athol U. Wells Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era Laurent Savale, Christophe Guignabert, Jason Weatherald, Marc Humbert Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018

Highlights in Acute Respiratory Failure

How should we monitor patients with acute respiratory failure treated with noninvasive ventilation? Begum Ergan, Jacek Nasilowski, João Carlos Winck Eur Respir Rev, 27 (148) 170101; 10.1183/16000617.0101-2017

Erratum

“Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050. Eur Respir Rev, 27 (148) 175050; 10.1183/16000617.5050-2017